by rss feed | Oct 24, 2026 | News Feeds
The Phase 2 BESTOW clinical trial showed that tegoprubart (a novel anti-CD40L antibody therapy) was better at preserving kidney function than tacrolimus (the current standard of care) in immunosuppressive regimens in adults receiving their first kidney transplant....
by rss feed | Oct 24, 2026 | News Feeds
New research indicates that commonly used measures of kidney function largely underestimate the prevalence of chronic kidney disease (CKD) in patients with cancer. The findings will be presented at ASN Kidney Week 2026 October 22–25. Read Original...
by rss feed | Oct 24, 2026 | News Feeds
An investigational vaccine helped the immune system recognize and respond to mutations that drive most pancreatic cancers, according to results from a randomized phase 2 clinical trial led by Mayo Clinic researchers. Read Original...
by rss feed | Oct 24, 2026 | News Feeds
Every egg cell and sperm cell depends on meiosis, a tightly choreographed process in which chromosomes find their partners, exchange genetic material, and then divide. Read Original...
by rss feed | Oct 24, 2026 | News Feeds
About 10% of cancers are linked to an inherited genetic variant, but as few as 1 in 15 cancer patients eligible for genetic testing complete it. Read Original...
